Mannan-binding protein (MBP) is an acute phase reactant, and its defic
iency:is associated with the common opsonic defect and suspectibility
to infections and atopic constitution. The aim of this study was to in
vestigate the changes occurring in the serum level of MBP in infancy a
nd during later childhood. We studied the serum concentration of MBP i
n 611 Finnish children of different ages and 110 adults by using an en
zyme immunoassay. In an analysis of successive serum samples from infa
nts at the day of birth and at the ages of 1 and 5 months, and at 1 an
d 2 years, the serum concentration of MBP increased significantly afte
r birth, and was at its highest (the mean and median were 8.13 and 8.4
9 mg l(-1), respectively) at the age oi 1 month. After that, it declin
ed to the initial level until the age of 5 months. The MBP concentrati
on continued to decrease during childhood, and after the age of 12 yea
rs the MBP values reached the adult level. In Finnish adults the mean
and median concentrations of MBP were 4.48 and 4.02 mg l(-1), respecti
vely, which seem to be higher than those reported previously in other
populations. The high concentration of MBP in infants may best be expl
ained by exposure to novel environmental antigens in early childhood,
which suggests a protective roll: for MBP during the period of immatur
ity of the immunosystem. In older children the high level of MBP can p
robably be explained by childhood infections and the ensuing need of M
BP.